Key Takeaways
- Amphetamine use disorder often begins with a legitimate prescription for Adderall, Vyvanse, or Dexedrine, and prescription amphetamines carry a misuse rate 3.1 times higher than methylphenidate products 8.
- Oklahoma treats stimulant use disorder through ODMHSAS-certified programs spanning withdrawal management, residential, and outpatient care, with SoonerCare and the IMD Waiver expanding coverage for residential beds 11.
- No FDA-approved medication exists for stimulant use disorder, so contingency management combined with CBT or community reinforcement remains the standard of care, alongside treatment for co-occurring ADHD, anxiety, or trauma 1.
- Before choosing a program in Oklahoma, ask about ODMHSAS Chapter 18 certification, how co-occurring conditions are assessed, and whether contingency management and CBT are core parts of daily care 13.
When the Adderall stops working the way it used to
Maybe it started with a prescription that actually helped. You could focus. You could finish the report, study for the exam, get through the shift. Then somewhere along the way, one pill stopped being enough. You started taking an extra dose to get the same lift. You ran out early. You borrowed from a friend, or you bought a few from someone who had extras. Now you are here, reading this, wondering if what you are doing has a name.
It does. And you are not the only person in Oklahoma asking this question. In 2024, about 1.5% of people aged 12 and older, roughly 4.3 million Americans, met criteria for a past-year CNS stimulant use disorder, a category that includes amphetamine products like Adderall, Vyvanse, and Dexedrine 5. That number includes people whose use started in a doctor’s office, not just people who bought something off the street.
If you are the family member who found the empty bottles two weeks before the refill date, or the parent looking at a college kid who has not slept in three days, this piece is for you too. Amphetamine use disorder does not always look the way you expect. Sometimes it looks like productivity that has quietly turned into something else.
This guide walks through what treatment actually involves in Oklahoma, how amphetamine use is different from methamphetamine use, what the evidence supports, and how a dual diagnosis program like Country Road Recovery approaches it. You do not have to have all the answers before you keep reading. You just have to keep reading.
Amphetamine use disorder is not the same thing as meth addiction
If you searched for amphetamine treatment and every result you found was about meth, that is confusing on purpose and also not your fault. The two are chemically related. They belong to the same drug family. But when you sit down with a clinician, they are usually asking about two different lives.
Amphetamine use disorder often starts with something a doctor handed you: Adderall for the ADHD diagnosis in college, Vyvanse for the binge eating, Dexedrine for narcolepsy. The pills are legal. The bottle has your name on it. The problem sneaks in through dose creep, borrowed pills, or the slow shift from swallowing to crushing. Methamphetamine use disorder, by contrast, tends to involve an illicit substance bought outside a pharmacy, often smoked or injected, and it carries a very different overdose risk profile 2.
Clinically, though, the overlap is real. The DSM criteria for stimulant use disorder cover both. You lose control of use. Tolerance climbs. Cravings show up between doses. Sleep, appetite, mood, and relationships start to bend around the drug. A treatment team will use the same diagnostic language whether your entry point was a prescription pad or a plastic bag 4.
The treatment framework overlaps too. There is no FDA-approved medication for stimulant use disorder of any kind, so the core of care is behavioral: contingency management, cognitive behavioral therapy, community reinforcement, and honest work on the anxiety or depression or trauma underneath 2. That is true whether you are trying to stop taking twice your prescribed Adderall dose or trying to stop using meth.
What that means for you: if you are on the prescription end of this spectrum, you belong in this conversation. You do not have to have hit some cinematic bottom to qualify for real help. And if your loved one has moved from pills to powder, that is not a separate story either. It is the same disorder, further along.
The prescription problem hiding in plain sight
There is a specific kind of shame that shows up when the drug causing you problems came in a bottle with your name on the label. You did what your doctor said. You picked it up at the pharmacy. And now you are taking more than prescribed, or taking someone else’s, or crushing a pill you were supposed to swallow, and the story you tell yourself does not match what is actually happening.
Here is what the research shows, so you can stop carrying this alone. A 2025 study in JAMA Network Open looked at US adults who were using prescription stimulants and found that 25.3% reported misuse and 9.0% met criteria for prescription stimulant use disorder 8. Read that scope carefully. It is not saying one in four Americans has this problem. It is saying that among adults already taking a prescription stimulant, roughly one in four is using it in a way the prescriber did not intend, and close to one in ten has crossed into a diagnosable disorder.
The same study found that people on amphetamine formulations, drugs like Adderall, Vyvanse, and Dexedrine, had a misuse rate 3.1 times higher and a use disorder rate 2.2 times higher than people on methylphenidate products like Ritalin and Concerta 8. If you feel like your Adderall has a different pull on you than your friend’s Ritalin seems to have on them, that is not in your head. The molecules behave differently, and the risk profile follows.
The path in often starts earlier than adulthood. A review of ADHD medication misuse found that roughly 5 to 10% of high school students and 5 to 35% of college students misuse prescription stimulants 9. Some of those students had a real diagnosis and slid into using the medication for studying, weight loss, or staying up. Others never had a prescription and got pills from someone who did. Either way, the college years leave a lot of people with a habit they carry into their twenties and thirties.
None of this means you are weak or broken or that your ADHD diagnosis was fake. It means the medication you were prescribed carries a real risk that most people are never told about clearly. If you started with a prescription that helped and now you are somewhere you did not plan to be, you are inside a well-documented pattern, not a personal failure. And there is a name for what you are experiencing, which means there is also a way through it.
How Oklahoma’s overdose picture pulls stimulants into focus
You might be wondering what any of this has to do with a state’s overdose numbers, especially if your situation looks nothing like the news coverage. Stay with this for a minute, because the way Oklahoma tracks stimulants is part of why help is available at all.
Methamphetamine sits at the sharpest end of the stimulant spectrum, and Oklahoma has watched that end grow for years. From 2007 to 2021, methamphetamine-related overdose deaths in the state rose more than 1,300%, from 39 deaths a year to 619 15. That is not a rounding error. That is a generation of families in Tulsa, Lawton, Shawnee, and small towns you have driven through on I-40, sitting in funeral homes because of a stimulant.
Prescription amphetamines like Adderall and Vyvanse do not typically cause fatal overdoses the way illicit stimulants can, especially when illicit supply is contaminated with fentanyl 3. So if you are reading this as a person taking too much of your prescription, this statistic is not describing your risk. It is describing the acute end of a spectrum that you are still on, just further back.
That distinction matters because it shapes what Oklahoma built. ODMHSAS now provides stimulant-inclusive services statewide, treating opioid and stimulant use disorders as connected priorities rather than separate silos 10. Certified programs exist because the state watched this curve climb and decided to fund a response. When you call one of them, you are not asking for a favor. You are using a system that was built, in part, because too many Oklahomans did not make it.
What evidence-based treatment actually looks like
If you have been picturing a hospital bed and an IV drip for a few days, that is not what stimulant treatment usually looks like. Amphetamine recovery does not have a medication protocol that resets your brain chemistry the way buprenorphine does for opioids. It has something else: a set of behavioral tools that, done consistently, actually work. Understanding that shift up front makes the rest of treatment make sense.
The medication gap and what fills it
Here is the honest part. No medication has been approved by the FDA to treat stimulant use disorder 2. That is a real gap, and it is worth naming instead of pretending otherwise. If a program tells you they have a pill that will fix your amphetamine use the way naltrexone can help with alcohol, be skeptical.
What clinicians can do is use certain medications off-label to help with specific pieces of the picture. The ASAM/AAAP guideline discusses options like bupropion, topiramate, and long-acting methylphenidate that some clinicians use under specific conditions, but these are not cures and they are not standard for everyone 1. They are tools a psychiatrist might reach for depending on your history and what else is going on.
The bigger point: when medication is not doing the heavy lifting, the therapy has to. That is not a downgrade. It is a redirect. The parts of your life that pulled you toward amphetamines, the ADHD that never got fully treated, the anxiety you were medicating without realizing it, the trauma you never sat with, are the parts a good program will actually work on.
Contingency management, CBT, and the community reinforcement approach
The ASAM/AAAP guideline names contingency management as the current standard of care for stimulant use disorders 1. In plain language, contingency management is a structured system that rewards you for measurable, verifiable progress, usually clean urine screens, session attendance, or completed treatment goals. It sounds simple. It works because it gives your brain something concrete to move toward while the natural reward system recalibrates from the amphetamine hijack.
Cognitive behavioral therapy is the second pillar. CBT teaches you to notice the thoughts that show up before a use decision, the ones that sound like just today or I need this to finish the project, and interrupt them before they become the plan. You will practice new responses, on paper and out loud, until they start to feel less foreign than the old ones.
The community reinforcement approach rounds out the trio. It rebuilds the life outside the drug: relationships, work, sleep, movement, meals, hobbies that used to matter. The CDC notes that combining contingency management with CBT or community reinforcement produces the best treatment outcomes in clinical studies 2. None of these are quick. All of them are learnable. And each week you stay with them, they get a little easier to trust.
Why co-occurring conditions decide most outcomes
Here is something most people do not hear early enough in this process: the amphetamine use is often the second thing, not the first. Something was already there when the pills started to matter more than they should have.
Sometimes it is ADHD that was real all along, but never fully treated, and the stimulant made you feel functional for the first time in your life. Sometimes it is anxiety you were medicating without calling it that, because caffeine and Adderall and one more cup of coffee felt like the only way to keep up. Sometimes it is depression that lifts, briefly, when you take an extra dose. Sometimes it is trauma sitting quietly in your body, and the drug is the volume knob that finally turns it down.
This is the piece that decides whether progress lasts. You can stop taking amphetamines for thirty days on willpower alone. Staying stopped, and building a life you do not have to escape, is different work. It means treating the whole person, not just the substance. If you are looking at programs in Oklahoma, ask specifically how they assess and treat co-occurring conditions. That answer tells you almost everything about the care you would actually get.
How Oklahoma’s treatment system is put together
You do not have to figure out Oklahoma’s treatment system on your own before you make a call. But knowing a little about how it is organized can help you ask better questions and worry less about ending up somewhere that does not fit. The state has more infrastructure than most people realize, and a lot of it was built with stimulant use specifically in mind.
Two pieces matter most when you are trying to find care for amphetamine use disorder. The first is who oversees the treatment programs and what levels of care exist. The second is how you pay for it, which for many Oklahomans means SoonerCare and a specific Medicaid waiver that changed what residential programs can bill for. Both pieces are worth understanding before you pick up the phone.
ODMHSAS, CCARCs, and the levels of care
The Oklahoma Department of Mental Health and Substance Abuse Services, ODMHSAS, is the state agency that funds, contracts with, and certifies most of the addiction treatment programs you will find here. Its statewide network includes community mental health centers, roughly 70 contracted SUD providers, 11 Certified Comprehensive Addiction Recovery Centers, and multiple levels of residential and withdrawal management 11. Stimulant use disorder, including amphetamine and methamphetamine, is treated as part of that network rather than as a side program 10.
The levels of care step down as you go. Withdrawal management for the first days off the drug. Residential treatment where you live on site while you do the therapy work. Halfway house and CCARC-level support as you stabilize. Then outpatient care that lets you return to work or school. Every certified program has to meet ODMHSAS Chapter 18 standards, which govern clinical staffing and how services are delivered 13.
What SoonerCare and the IMD Waiver cover
If you are on SoonerCare, Oklahoma’s Medicaid program, your behavioral health benefits already include inpatient acute care, crisis stabilization, and medical detoxification 12. That matters because stimulant treatment often starts with a few days of stabilization before the real therapy work begins, and you should not have to front that cost yourself.
The bigger change came through the state’s IMD Waiver, a federal Medicaid demonstration that lets SoonerCare pay for residential SUD treatment in facilities that used to be excluded from Medicaid billing 11. In plain terms, more residential beds became reachable for people who could not have afforded them before. If you have private insurance, the coverage picture is different, but the same waiver reshaped what treatment programs across the state can offer.
When residential care makes sense, and what to ask before you go
Not everyone with amphetamine use disorder needs to leave home to get well. Some people do better in intensive outpatient a few evenings a week, sleeping in their own bed, keeping their job. Others need to step out of the environment entirely for a while, because the desk where they study, the roommate who sells, or the routine that ends with a pill at 3 p.m. is too woven into the use to unravel from inside it.
Residential care tends to make sense when:
- You have tried to stop on your own and it has not held.
- Your mental health is unstable enough that you are not safe managing it alone.
- The people around you are also using.
- The co-occurring anxiety, depression, ADHD, or trauma is loud enough that behavioral therapy needs uninterrupted time to work.
If you cannot picture yourself getting through a single week without using, that is useful information, not a character verdict.
Before you commit to a program, get real answers to a short list of questions:
- Are they certified under ODMHSAS Chapter 18 standards 13?
- How do they assess and treat co-occurring mental health conditions, not just the substance use 4?
- Do they use contingency management and CBT as core parts of the program, since those are the current standard of care for stimulant use disorders 1?
- Will they coordinate with a psychiatrist if off-label medication is worth considering?
- What does the step-down look like when you leave, and who helps you build it?
You do not need to know the perfect way to ask any of this. You just need to say, out loud, that you are looking for help with amphetamine use, and let someone on the other end of the line do the rest of the work with you.
How Country Road Recovery approaches amphetamine use disorder
Country Road Recovery Center sits on 136 acres in Pink, Oklahoma, a rural stretch between Shawnee and Oklahoma City. The setting is part of the point. Amphetamine recovery asks you to slow down a nervous system that has been running above baseline for months or years, and that is easier to do somewhere quiet than somewhere loud.
The program treats amphetamine use disorder inside a dual diagnosis framework, meaning your clinical team looks at the prescription stimulant misuse or the shift from Adderall to street amphetamines alongside the ADHD, anxiety, depression, or trauma that was likely there first 4. Care is individualized rather than run through a fixed track. Residential, PHP, and IOP levels are available so the step-down is built in, not improvised. Clinical work draws on CBT and DBT, trauma-focused therapy, and experiential modalities like equine and art therapy. Many staff members are in long-term recovery themselves, which changes the room in ways brochures cannot really capture.
If you want to know exactly how they assess and treat amphetamine use disorder, including which behavioral therapies they use and how they handle co-occurring psychiatric care, ask them directly. That is the most useful phone call you can make today.
Take the First Step Toward Real Recovery
Connect with a team ready to support your recovery from amphetamine addiction, starting with a confidential conversation.
Frequently Asked Questions
Is misusing my Adderall or Vyvanse prescription really the same as having an addiction?
It can be. Clinicians use the same diagnostic criteria for stimulant use disorder whether the drug came from a pharmacy or elsewhere: loss of control, tolerance, cravings, and use that keeps going despite consequences 4. If you are taking more than prescribed, running out early, or getting pills from other people, that pattern has a name and a treatment path. It is not a character problem.
Is amphetamine addiction treatment different from meth addiction treatment?
The framework is largely the same. Both fall under stimulant use disorder, and the evidence-based core, contingency management with CBT or community reinforcement, applies to both 2. What differs is context: entry pathway, overdose risk, medical stabilization needs, and the co-occurring conditions clinicians address. A good program tailors the plan to your history rather than treating every stimulant patient the same way.
Is there a medication that treats amphetamine use disorder the way Suboxone treats opioids?
No. The FDA has not approved any medication for stimulant use disorder 1. Some clinicians use options like bupropion, topiramate, or long-acting methylphenidate off-label in specific cases, but these are not cures and are not standard for everyone 1. The evidence base sits with behavioral therapy. If a program promises a pill that fixes amphetamine use the way Suboxone helps with opioids, ask more questions.
Does SoonerCare cover residential treatment for amphetamine use disorder in Oklahoma?
SoonerCare behavioral health benefits include inpatient acute care, crisis stabilization, and medical detoxification 12. Oklahoma’s IMD Waiver also expanded Medicaid coverage for residential SUD treatment in facilities that used to be excluded, which broadened access to residential beds across the state 11. Coverage specifics depend on your plan and the certified program, so call the program directly and ask them to verify your benefits before you commit.
How do I know if my loved one needs residential care or if outpatient treatment is enough?
Residential care tends to fit when outpatient attempts have not held, when mental health is unstable, when the home environment is tied to the use, or when co-occurring anxiety, depression, ADHD, or trauma needs uninterrupted attention 4. Outpatient can work when someone has stable housing, real support, and can stay safe between sessions. A clinical assessment sorts this out honestly. You do not have to guess the level of care alone.
What should I ask a treatment program before admitting for amphetamine use?
Ask if they are certified under ODMHSAS Chapter 18 standards 13, how they assess and treat co-occurring mental health conditions 4, and whether contingency management and CBT are core parts of the program, since those are the current standard of care 1. Ask how they coordinate psychiatric care if off-label medication is considered, and what the step-down to PHP, IOP, or aftercare looks like when residential ends.
References
- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. https://stacks.cdc.gov/view/cdc/156927/cdc_156927_DS1.pdf
- Stimulant Guide: Answers to Emerging Questions about Stimulants in the Context of the Overdose Epidemic. https://www.cdc.gov/overdose-prevention/media/pdfs/2024/03/CDC-Stimulant-Guide.pdf
- Stimulants | Overdose Prevention. https://www.cdc.gov/overdose-prevention/about/stimulant-overdose.html
- Chapter 1—Introduction – Treatment for Stimulant Use Disorders. https://www.ncbi.nlm.nih.gov/books/NBK576544/
- Results from the 2024 National Survey on Drug Use and Health. https://www.samhsa.gov/data/sites/default/files/reports/rpt56287/2024-nsduh-annual-national/2024-nsduh-annual-national-html-071425-edited/2024-nsduh-annual-national.htm
- What is the scope of prescription drug misuse in the United States?. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-scope-prescription-drug-misuse
- Burden of drug use disorders in the United States from 1990 to 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC11188227/
- Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults. https://pubmed.ncbi.nlm.nih.gov/40105821/
- The potential for misuse and abuse of medications in ADHD: a review. https://pubmed.ncbi.nlm.nih.gov/25295651/
- Adult and Family Services – ODMHSAS. https://oklahoma.gov/odmhsas/treatment/adult-family-treatment-services.html
- Oklahoma IMD Waiver for Serious Mental Illness and Substance Use Disorder. https://www.medicaid.gov/medicaid/section-1115-demonstrations/downloads/ok-imd-waiver-smi-sud-pa.pdf
- Behavioral Health and Substance Abuse Services – Oklahoma Medicaid (SoonerCare). https://oklahoma.gov/ohca/individuals/mysoonercare/soonercare-benefits/behavioral-health-and-substance-abuse-services.html
- Chapter 18. Standards and Criteria for Substance Related and Addictive Disorder Treatment Services. https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/policy/provider-certification/administrative-rules/2021/Chapter%2018%20Final%20effective%209-15-21.pdf
- Drug Overdose Deaths, 2019–2023 (Oklahoma State Fact Sheet). https://oklahoma.gov/content/dam/ok/en/health/health2/aem-documents/prevention-and-preparedness/injury-prevention/drug-overdose/2025%20State%20Drug%20OD%20-%20IPS%20-%20Fact%20Sheet.pdf
- Scope of the Problem (Oklahoma Methamphetamine Overdose Report). https://digitalprairie.ok.gov/digital/api/collection/stgovpub/id/641244/download
- Unintentional Drug Overdose Data – Oklahoma State Department of Health. https://oklahoma.gov/health/health-education/injury-prevention-service/drug-overdose/data.html
- Drug Overdose Data Graphs and Maps – Oklahoma State Department of Health. https://oklahoma.gov/content/dam/ok/en/health/health2/aem-documents/prevention-and-preparedness/injury-prevention/drug-overdose/Drug%20Overdose%20Data%20Graphs%20and%20Maps.pdf
- Fatal Overdose Data (Oklahoma). https://digitalprairie.ok.gov/digital/api/collection/stgovpub/id/728296/download
- Drug Overdose County Fact Sheets, 2022. https://digitalprairie.ok.gov/digital/collection/stgovpub/id/641285/
- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. https://stacks.cdc.gov/view/cdc/156927